RARE DISEASES A–Z · LETTER F

Friedreich Ataxia

Friedreich ataxia is the most common inherited ataxia. It is caused by too little of a mitochondrial protein called frataxin, which slowly damages the spinal cord and balance systems — and, importantly, the heart. It usually begins in late childhood or the teenage years.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Friedreich ataxia is a recessive gene condition: too little frataxin protein damages balance pathways and the heart. It starts in childhood or the teens with progressive clumsiness. A first progression-slowing medicine exists; heart monitoring is essential.

The guide

The basics

The FXN gene normally makes frataxin, a protein that helps mitochondria — the cell's energy generators — handle iron safely. In Friedreich ataxia an expanded DNA repeat (GAA) inside the gene reduces frataxin to a fraction of normal. Energy-hungry cells suffer first: nerve cells carrying sensation from the legs, the spinal cord pathways for balance, and the cerebellum. The result is progressive clumsiness and falls, slurred speech, and loss of joint position sense, usually beginning between ages 5 and 15. The same protein shortage affects other organs: the heart thickens (hypertrophic cardiomyopathy — the main threat to life), diabetes develops in a significant minority, and scoliosis and foot deformity (high arches) are common. Intelligence is not affected.

How it works

Genetic testing for the GAA expansion in FXN confirms the diagnosis in the great majority of cases and can be done at any age; the size of the expansion roughly predicts how early symptoms begin. Neurological examination shows the distinctive combination of ataxia with absent reflexes but upgoing plantar responses, and reduced vibration and position sense. Because the heart determines prognosis, assessment includes ECG and heart imaging at diagnosis and regularly afterwards, plus blood sugar checks, spine review, hearing and vision checks, and swallowing assessment if needed. The differential diagnosis includes other childhood ataxias and vitamin E deficiency, which is treatable — one reason specialist assessment matters even when the picture seems classic.

Day to day

Care combines the first disease-modifying medicine with strong supportive management. The approved tablet treatment (an Nrf2 activator) modestly slows neurological progression in people aged 16 and over and is taken long-term; trials in children and of other approaches — including gene therapy and frataxin replacement — are ongoing. Physiotherapy maintains mobility, balance strategies, and posture; occupational therapy adapts tasks as hand control changes; speech therapy supports speech and swallowing. Scoliosis may need bracing or surgery. Heart treatment follows cardiomyopathy practice, including rhythm management, and diabetes is treated conventionally. Mobility aids and, in time, wheelchairs preserve independence rather than mark defeat — planning ahead keeps people active at school, work, and home.

When to get help

Follow-up at an ataxia or neuromuscular centre coordinates neurology, cardiology, diabetes, orthopaedics, and therapy reviews. Heart surveillance continues even when you feel well — cardiomyopathy can progress silently and drives the monitoring schedule. Report palpitations, fainting, chest pain, or new breathlessness promptly. Vaccinations and prompt treatment of chest and urinary infections protect a system with little reserve. Genetic counselling explains the recessive pattern: parents are healthy carriers, each sibling has a 1-in-4 chance of being affected, and carrier testing is available for partners and adult relatives who want it.

See a doctor promptly if: Palpitations, fainting, chest pain, or breathlessness in someone with Friedreich ataxia needs urgent assessment — heart involvement is the main danger.

Common questions

Who was Friedreich?

Friedreich ataxia is named after Nikolaus Friedreich, the German neurologist who described the condition in the 1860s. It remains the most common of the inherited ataxias in people of European ancestry.

How is it different from Huntington disease?

In Friedreich ataxia both copies of the gene must carry the expansion (recessive inheritance) — carriers with one copy are healthy. Huntington disease needs only one faulty copy (dominant). The two also differ in the protein involved and the parts of the nervous system most affected.

Will I need a wheelchair?

Most people eventually use a wheelchair for longer distances, typically within 10 to 15 years of symptoms starting, though the timeline varies considerably. Upper-limb and speech involvement progress too, which is why therapy and equipment planning run ahead of need.

Is there any treatment that changes the disease?

Yes — the first disease-modifying medicine, a tablet that activates the Nrf2 pathway to reduce oxidative stress in cells, has been approved in several countries for people aged 16 and over, with trials continuing in younger patients. It slows rather than stops progression, and more approaches are in development.

More in Letter F

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Cardiac monitoring and therapy plans are individual; follow your ataxia centre's advice.